🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 14 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 05/11/2013 | 43,50 | 43,68 | 43,24 | 43,28 | -0,79% | 1,01% | 10.920.684 |
| 04/11/2013 | 43,82 | 44,15 | 43,57 | 43,63 | +1,08% | 1,33% | 16.954.020 |
| 01/11/2013 | 42,81 | 43,27 | 42,58 | 43,16 | +0,31% | 1,63% | 21.896.388 |
| 31/10/2013 | 43,23 | 43,38 | 43,02 | 43,02 | -0,33% | 0,82% | 15.713.922 |
| 30/10/2013 | 43,65 | 43,66 | 43,04 | 43,17 | -0,75% | 1,42% | 10.436.508 |
| 29/10/2013 | 43,33 | 43,58 | 43,02 | 43,49 | +0,51% | 1,30% | 16.652.720 |
| 28/10/2013 | 43,48 | 43,72 | 43,14 | 43,27 | -2,56% | 1,34% | 28.607.885 |
| 25/10/2013 | 44,13 | 44,45 | 43,75 | 44,41 | +0,69% | 1,58% | 18.752.912 |
| 24/10/2013 | 44,66 | 44,71 | 44,07 | 44,10 | -0,73% | 1,43% | 11.738.753 |
| 23/10/2013 | 44,47 | 44,58 | 44,35 | 44,43 | +0,19% | 0,52% | 10.113.934 |
| 22/10/2013 | 44,19 | 44,58 | 44,03 | 44,34 | -0,09% | 1,25% | 16.601.892 |
| 21/10/2013 | 44,56 | 44,58 | 43,97 | 44,38 | -0,21% | 1,37% | 17.478.544 |
| 18/10/2013 | 45,20 | 45,28 | 44,34 | 44,48 | -1,06% | 2,07% | 21.622.755 |
| 17/10/2013 | 44,97 | 45,11 | 44,74 | 44,95 | -0,13% | 0,83% | 14.544.668 |
| 16/10/2013 | 44,48 | 45,01 | 44,44 | 45,01 | +1,29% | 1,29% | 11.635.630 |
| 15/10/2013 | 44,39 | 44,69 | 44,29 | 44,44 | -0,39% | 0,88% | 14.840.728 |
| 14/10/2013 | 44,66 | 44,92 | 44,31 | 44,61 | -1,14% | 1,37% | 21.666.876 |
| 11/10/2013 | 45,25 | 45,31 | 44,99 | 45,12 | -0,42% | 0,72% | 10.745.668 |
| 10/10/2013 | 45,42 | 45,45 | 44,81 | 45,31 | +0,47% | 1,41% | 18.090.995 |
| 09/10/2013 | 45,51 | 45,63 | 44,98 | 45,11 | -1,01% | 1,43% | 16.090.363 |
| 08/10/2013 | 45,65 | 45,94 | 45,46 | 45,56 | -0,29% | 1,07% | 14.693.694 |
| 07/10/2013 | 45,73 | 46,02 | 45,50 | 45,70 | -0,70% | 1,15% | 9.637.198 |
| 04/10/2013 | 46,06 | 46,15 | 45,74 | 46,02 | -0,27% | 0,87% | 12.126.198 |
| 03/10/2013 | 46,01 | 46,52 | 45,80 | 46,15 | -0,02% | 1,56% | 18.759.724 |
| 02/10/2013 | 46,23 | 46,33 | 45,92 | 46,15 | -0,76% | 0,89% | 14.646.114 |
| 01/10/2013 | 46,68 | 46,98 | 45,94 | 46,51 | +2,37% | 2,21% | 28.651.482 |
| 30/09/2013 | 45,46 | 45,68 | 45,12 | 45,43 | -0,38% | 1,22% | 17.023.712 |
| 27/09/2013 | 45,39 | 45,72 | 45,12 | 45,60 | +0,23% | 1,30% | 11.014.794 |
| 26/09/2013 | 45,59 | 45,80 | 45,33 | 45,50 | +0,02% | 1,03% | 10.753.633 |
| 25/09/2013 | 45,49 | 45,79 | 45,25 | 45,49 | +0,29% | 1,20% | 11.901.402 |